Kinsa commits to democratizing access to real-time health information by building the world's first real-time map of human health and illness. This map will enable individuals to seek appropriate treatment faster and better, enable doctors and nurses to better diagnose and care for patients, and enable health systems to, for the first time ever, track in real-time the spread of illness and potentially stop it.
To achieve this, Kinsa will build a unique set of mobile products and software. This will include internet-enabled medical devices that will be donated to vulnerable populations, as well as a platform that both individuals and health systems can access freely.
Kinsa brings together expertise in mobile software and hardware development, design, the development of successful global programs and ventures, and expertise in market-based approaches for healthcare. Its founder, executives, and board have started several successful ventures, invented next generation technologies, and led international health programs that have enabled millions of people to access life-savings treatments.
Announce 2013 CGI commitment: May 2013
Announce partnerships for enabling vulnerable populations with access: October 2013-March 2014
Scale access of health information platform to 5M people by end-2016
Currently, Kinsa is in partnership talks with Cook Hospital, PedsPal, Genentech/Tamiflu, CVS and CVS Minute Clinic, Wal-Mart, and 2 pediatrician groups. Kinsa has also have received a letter of intent for the distribution of 80,000 products via pediatricians to patients. Kinsa will sell the product at production cost to paying pediatricians, but mothers would have free access to the products.
As Larry Brilliant said in his 2006 TED Talk upon receiving the TED Prize, the solution to stopping the spread of disease is 'early detection and early response.'
There is limited access to real-time localized health information. This results in health interventions having a limited impact on an individual and population level. For example, nearly 1 in 5 people globally were infected by Swine Flu in 2009, despite the hundreds of billions of dollars spent to stop the spread of this disease. One crucial resource missing to limit the spread of swine flu was the lack of real-time data about the spread. A second example is SARS in 2002. SARS spread to more than 20 countries in a matter of a few weeks with limited knowledge of its spread prior to this. Again, the lack of real-time information was an underlying issue. A third example is in malaria, where there is limited knowledge of the specific number of and location of cases, only broad estimates based on a cascading set of error-prone assumptions that many experts call into question.
The dearth of information about the health situation surrounding us is shocking when one considers how advanced our technologies have become. In today's world, we have tremendous access to many kinds of real-time information: where our friends are located (via Facebook, Foursquare), how to get downtown quickly (via GoogleMaps and Waze), and so forth. Now is the time to improve and democratize access to the health situation around us. In doing so, this will enable individuals to seek appropriate treatment faster and better, enable doctors and nurses to better diagnose and care for patients, and enable health systems to, for the first time ever, track in real-time the spread of illness and potentially stop it.
Kinsa expects to announce its 2013 commitment in the 3rd or 4th quarter following a public announcement of its first product. The organization is looking for partners to take its products and distribute them to vulnerable populations with limited access to health services. These organizations should have a presence in the US, knowledge of health information products and services, and distribution channels to vulnerable populations with limited access to health services. Major hospital systems (like Kaiser or UPMC), public health agencies (e.g., Health and Human Services in the US , UK's National Health Service, or state/ provisional or regional health agencies) in the US or Europe, or nonprofit foundations or health services organizations would serve as great partners. Kinsa expects to donate or find other mechanisms to support the availability of these products at no cost.